These results indicate that NBP alleviates cognitive impairment following CCH by promoting remyelination and suppressing inflammation via modulation of AMPK/SIRT1 and STAT3/NF-κB signaling. This evidence concerns the gene STAT3 and columnar cell hyperplasia of the breast.